Vur Pharma Private Limited
About Vur Pharma Private Limited
Data last updated:
Vur Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 02 June 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2022PTC163404.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Ram Reddy Nagi Reddy Palli and Pally Anuradha Nagireddy.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H. No. 228 Road No. 10 Vemana Colony Chandanagar, Hyderabad, Telangana, India – 500050.
As per the financials filed for FY 2024, the company reported a revenue of ₹32.72 Lakh, a decline of 71% compared to the previous year. For the same year it recorded a net loss of ₹1.15 Lakh (net margin -3.5%) and EBITDA of -₹1.15 Lakh (EBITDA margin -3.5%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH. No. 228 Road No. 10 Vemana Colony Chandanagar, Hyderabad, Telangana, India – 500050
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vur Pharma Private Limited
The main business activity of Vur Pharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vur Pharma Private Limited FY 2024 filings available
Vur Pharma Private Limited reported revenue of ₹32.72 Lakh (down 71% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Vur Pharma Private Limited
Revenue fell 71% in the latest year. EBITDA fell 713% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Vur Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹1.15 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹1.15 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Vur Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -3.5% | •••• |
| Net Profit Margin | -3.5% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vur Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Vur Pharma Private Limited
Vur Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Swasthmay India Clinics Private Limited | ₹32.76 Lakh (FY 2024) | •••• | •••• | 73.0% | •••• | Delhi, India |
| Amakan Industries Private Limited | ₹32.75 Lakh (FY 2024) | •••• | •••• | 114.0% | •••• | Kolkata, West Bengal, India |
| Andrea Lifesciences Private Limited | ₹32.74 Lakh (FY 2022) | •••• | •••• | 46.0% | •••• | Brahampuriranhola, Delhi, India |
| Yatrikan Services Private Limited | ₹32.73 Lakh (FY 2023) | •••• | •••• | 29.0% | •••• | Hyderabad, Telangana, India |
| Sparsh Stem Cell Private Limited | ₹32.73 Lakh (FY 2016) | •••• | •••• | -33.0% | •••• | Mumbai, Maharashtra, India |
| Vur Pharma Private Limited this company | ₹32.72 Lakh (FY 2024) | •••• | •••• | -71.0% | •••• | Hyderabad, Telangana, India |
| Devayu Shree Exports Private Limited | ₹32.72 Lakh (FY 2022) | •••• | •••• | -55.0% | •••• | Barwaha, Madhya Pradesh, India |
| Daylove Care India Private Limited | ₹32.72 Lakh (FY 2025) | •••• | •••• | 491.0% | •••• | Gondal, Gujarat, India |
| Kitn Informatics Private Limited | ₹32.72 Lakh (FY 2019) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Ssaeroes Enterprises Private Limited | ₹32.7 Lakh (FY 2021) | •••• | •••• | -25.0% | •••• | Hyderabad, Telangana, India |
| Gaharwar Manufacturers Private Limited | ₹32.69 Lakh (FY 2024) | •••• | •••• | 113.0% | •••• | Varanasi, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Vur Pharma by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Vur Pharma Private Limited
Vur Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ram Reddy Nagi Reddy Palli Also directs: Manjeeramavillu Mango Farmers Producer Company Limited | Director | 02 Jun 2022 | 4 Years 4 Months | Current |
| Pally Anuradha Nagireddy | Director | 19 Aug 2022 | 4 Years 1 Months | Current |
Charges & Borrowings of Vur Pharma Private Limited
Vur Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Vur Pharma Private Limited
Employment history and EPFO contributions of people linked to Vur Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vur Pharma Private Limited
Vur Pharma Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Nagireddypally Sushma ceased to be Director on 19 Aug 2022.
Credit Ratings, Litigation & Regulatory Alerts for Vur Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vur Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vur Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vur Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vur Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vur Pharma Private Limited
Vur Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty, within the trading industry. It was incorporated on 02 June 2022 (4+ years old) and is registered under CIN U51909TG2022PTC163404.
Vur Pharma reported revenue of ₹32.72 Lakh for FY 2024 (down 71% YoY).
Vur Pharma has 2 current directors:
- Ram Reddy Nagi Reddy Palli - Director
- Pally Anuradha Nagireddy - Director
Vur Pharma reported a net loss of ₹1.15 Lakh (net margin -3.5%) and EBITDA of -₹1.15 Lakh (EBITDA margin -3.5%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Vur Pharma is U51909TG2022PTC163404. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vur Pharma was incorporated on 02 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Vur Pharma by revenue are Swasthmay India Clinics Private Limited, Amakan Industries Private Limited, Andrea Lifesciences Private Limited, Yatrikan Services Private Limited, Sparsh Stem Cell Private Limited and 5 more, all in the same principal business activity (Retail Trading).
Nagireddypally Sushma ceased to be Director on 19 Aug 2022. Pally Anuradha Nagireddy was appointed as Director on 19 Aug 2022. Ram Reddy Nagi Reddy Palli was appointed as Director on 02 Jun 2022.
The registered office of Vur Pharma is at H. No. 228 Road No. 10 Vemana Colony Chandanagar, Hyderabad, Telangana, India – 500050.
Vur Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh.
Vur Pharma operates in the trading industry, in the specialty segment.